Does length of symptoms before diagnosis of sarcoma affect patient survival?

Clinical Orthopaedics and Related Research

Volumn 462, Issue , 2007, Pages 181-189

  Rougraff, Bruce T ^a,c   Davis, Kenneth ^b   Lawrence, Jackie ^c  

^a ST VINCENT HOSPITAL   (United States)

^b Department of Statistics   (United States)

^c Orthopaedic Indianapolis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SARCOMA; SURVIVAL; SYMPTOM; TUMOR LOCALIZATION; TUMOR VOLUME; BONE TUMOR; FOLLOW UP; KAPLAN MEIER METHOD; MORTALITY; PROPORTIONAL HAZARDS MODEL; SOFT TISSUE TUMOR; SURVIVAL RATE; TIME;

BONE NEOPLASMS; DISEASE-FREE SURVIVAL; EARLY DIAGNOSIS; FOLLOW-UP STUDIES; KAPLAN-MEIERS ESTIMATE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 34548433487     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e3180f62608     Document Type: Article

References (34)

1. Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS patients: cancer. Br J Cancer. 2005;92:1959-1970.
2. Andrews BT, Bates T. Delay in the diagnosis of breast cancer: medico-legal implications. Breast. 2000;9:223-237.
3. Baker LH, Frank J, Fine G, Balcerzak SP, Stephens RL, Stuckey WJ, Rivkin S, Saiki J, Ward JH. Combination chemotherapy using Adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcoma: a randomized comparative trial. A Phase III, Southwest Oncology Group study (7613). J Clin Oncol. 1987;5:851-861.
4. Barber MD, Jack W, Dixon JM. Diagnostic delay in breast cancer. Br J Surg. 2004;91:49-53.
5. Barker LM, Pendergrass TW, Sanders JE, Hawkins DS. Survival after recurrence of Ewing's sarcoma family of tumors. J Clin Oncol. 2005;23:4354-4362.
6. Bharucha S, Hughes S, Kenyan V, Anderson ID, Carlson GL, Scott NA. Targets and elective colorectal cancer: outcome and symptom delay at surgical resection. Colorectal Dis. 2005;7:169-171.
7. Borden EC, Amato DA, Edmonson JH, Ritch PS, Shiraki M. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer. 1990;66:862-867.
8. Brouns F, Stas M, De Wever I. Delay in diagnosis of soft tissue sarcomas. Eur J Surg Oncol. 2003;29:440-445.
9. Clark MA, Thomas JM. Delay in referral to a specialist soft-tissue sarcoma unit. Eur J Surg Oncol. 2005;31:443-448.
10. Cormier JN, Huang X, Xing V, Thall PF, Wang X, Benjamin RS, Pollock RE, Antonescu CR, Maki RG, Brennan MF, Pisters PW. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol. 2004;22:4567-4574.
11. Damron TA, Beauchamp CP, Rougraff BT, Ward WG. Soft-tissue lumps and bumps. Instr Course Lect. 2004;53:625-637.
12. Epstein JB, Lunn R, Le ND, Stevenson-Moore P, Gorsky M. Patients with oropharyngeal cancer: a comparison of adults living independently and patients living in long-term care facilities. Spec Care Dentist. 2005;25:124-130.
13. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat. 1997;45:263-270.
14. Gonzolez-Hermoso F, Perez-Palma J, Marchena-Gomez J, Lorenzo-Rocha N, Medina-Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg. 2004;28:716-720.
15. Graefen M, Walz J, Chun KH, Schlomm T, Haese A, Huland H. Reasonable delay of surgical treatment in men with localized prostate cancer: impact on prognosis? Eur Urol. 2005;47:756-760.
16. Haimi M, Peretz Nahum M, Ben Arush MW. Delay in diagnosis of children with cancer: a retrospective study of 315 children. Pediatr Hematol Oncol. 2004;21:37-48.
17. Hussein R, Smith MA. Soft tissue sarcomas: are current referral guidelines sufficient? Ann R Coll Surg Engl. 2005;87:171-173.
18. Khan MA, Mangold LA, Epstein JI, Boitnott JK, Walsh PC, Partin AW. Impact of surgical delay on long-term cancer control for clinically localized prostate cancer. J Urol. 2004;172:1835-1839.
19. Langlands AO, Gebski V, Hirsch D, Tattersall MH. Delay in diagnosis of breast cancer: estimating its effect on prognosis, with particular reference to medical litigation. Breast. 2002;11:386-393.
20. Liedberg F, Anderson H, Mansson A, Mansson W. Diagnostic delay and prognosis in invasive bladder cancer. Scand J Urol Nephrol. 2003;37:396-400.
21. Lydiatt DD. Medical malpractice and head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2004;12:71-75.
22. Maconi G, Kurihara H, Panizzo V, Russo A, Cristaldi M, Marrelli D, Roviello F, de Manzoni G, Di Leo A, Morgagni P, Bechi P, Bianchi Porro G, Taschieri AM. Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol. 2003;38:1249-1255.
23. McGurk M, Chan C, Jones J, O'Regan E, Sherriff M. Delay in diagnosis and its effect on outcome in head and neck cancer. Br J Oral Maxillofac Surg. 2005;43:281-284.
24. Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, LaQuaglia M. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol. 1993;11:449-453.
25. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-312.
26. Montella M, Crispo A, Botti G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, D'Aiuto G. An assessment of delay in obtaining definitive breast cancer treatment in southern Italy. Breast Cancer Res Treat. 2001;66:209-215.
27. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Stahle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004;59:45-49.
28. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, Andersson I, Bjurstam N, Fagerberg G, Frisell J. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet. 1993;341:973-978.
29. Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Pericles P, Davi A, Prospero JD, Alves MT, Oliveira CR, Macedo CR, Mendes WL, Almeida MT, Borsato ML, dos Santos TM, Ortega J, Consentino E. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol. 2006;24:1161-1167.
30. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1995;13:1537-1545.
31. Scott SE, Grunfeld EA, McGurk M. The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol. 2005;41:396-403.
32. Toth-Fejel S, Pommier RF. Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumor. Am J Surg. 2004;187:575-579.
33. Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastases. J Bone Joint Surg Am. 1990;72:60-68.
34. Wurtz LD, Peabody TD, Simon MA. Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg Am. 1999;81:317-325.